SCHEMBL10104519

SCHEMBL10104519

COCCN(C)Cc1cc(C(F)(F)F)cc(C)c1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.34
TACR1 P25103 3/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
PRMT3 O60678 1/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32
PRMT1 Q99873 1/20 0.32
PRMT8 Q9NR22 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
ADRA1D P25100 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104511 0.82 CYP3A4 (0.42) HTTALDH1A1GAAMEN1MAPT
SCHEMBL10104499 0.80 SLC6A2 (0.34) HTTALDH1A1GAAMEN1MAPT
SCHEMBL10104475 0.74 CYP2C19 (0.41) HTTMEN1KMT2AKDM4EDRD3
SCHEMBL10104520 0.74 TACR1 (0.40) ALDH1A1MEN1KMT2AKDM4ETACR1
SCHEMBL15743685 0.71 RAPGEF4 (0.39) ALDH1A1GAASMN1; SMN2
SCHEMBL10104510 0.70 SLC6A2 (0.36) HTTALDH1A1GAAMEN1MAPT
SCHEMBL10104491 0.69 MEN1 (0.35) HTTALDH1A1GAAMEN1MAPT
SCHEMBL10104434 0.68 CYP2C19 (0.56) HTTALDH1A1GAAMEN1MAPT
SCHEMBL5110263 0.68 SLC6A4 (0.46) HTTMAPTSLC6A2SLC6A4
SCHEMBL14948896 0.66 CHRM2 (0.46) HTTALDH1A1GAAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 HTT 3459/4885ALDH1A1 175/4885GAA 716/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 HTT 4227/4885ALDH1A1 860/4885GAA 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.